In 2011, research from John Laterra’s group showed that MET is activated and functional in glioblastoma neurospheres that harbor a large population of glioblastoma stem cells, and in fact, MET expression correlates with and induces the expression of stem cell markers and reprogramming transcription factors [44]. The gene discussed is MET; the disease is glioblastoma.